$TRIB

TRINITY BIOTECH PLC

CIK:0000888721|SEC Filings

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Disclosure of classes of share capital [line items]
Revenues	$ 43,785,000	$ 61,555,000	$ 56,832,000
Cost of sales	(26,898,000)	(40,114,000)	(37,382,000)
Gross profit	16,887,000	21,441,000	19,450,000
Other operating income/(expense)	1,870,000	(1,787,000)	141,000
Research and development expenses	(3,629,000)	(4,543,000)	(4,379,000)
Selling, general and administrative expenses	(24,674,000)	(28,815,000)	(31,152,000)
Selling, general and administrative expenses – Transformation costs	(4,252,000)	(4,181,000)	0
Once off items	186,000	(1,872,000)	0
Impairment charges	(2,177,000)	(1,408,000)	(11,105,000)
Operating loss	(15,789,000)	(21,165,000)	(27,045,000)
Financial income	0	0	1,171,000
Financial expenses	(21,388,000)	(9,565,000)	(11,053,000)
Net financing expense	(21,388,000)	(9,565,000)	(9,882,000)
Loss before tax	(37,177,000)	(30,730,000)	(36,927,000)
Total income tax (expense)/credit	(199,000)	(486,000)	59,000
Loss for the year on continuing operations	(37,376,000)	(31,216,000)	(36,868,000)
(Loss)/profit for the year on discontinued operations	0	(573,000)	12,850,000
Loss for the year (all attributable to owners of the parent)	(37,376,000)	(31,789,000)	(24,018,000)
American depositary share [Member]
Disclosure of classes of share capital [line items]
Loss for the year (all attributable to owners of the parent)	$ (37,376,000)	$ (31,789,000)	$ (24,018,000)
Basic loss per ADS (US Dollars) – continuing operations	$ (2)	$ (1.7)	$ (4.8)
Diluted loss per ADS (US Dollars) – continuing operations	(2)	(1.7)	(4.8)
Basic loss per ADS (US Dollars) – group	(2)	(1.8)	(3.1)
Diluted loss per ADS (US Dollars) – group	$ (2)	$ (1.8)	$ (3.1)
Class A Ordinary shares [Member]
Disclosure of classes of share capital [line items]
Loss for the year (all attributable to owners of the parent)	$ (37,376,000)	$ (31,789,000)	$ (24,018,000)
Basic loss per ADS (US Dollars) – continuing operations	$ (0.1)	$ (0.1)	$ (0.2)
Diluted loss per ADS (US Dollars) – continuing operations	(0.1)	(0.1)	(0.2)
Basic loss per ADS (US Dollars) – group	(0.1)	(0.1)	(0.2)
Diluted loss per ADS (US Dollars) – group	$ (0.1)	$ (0.1)	$ (0.2)

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Loss for the year	$ (37,376)	$ (31,789)	$ (24,018)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation	1,299	675	831
Amortisation	1,385	1,190	946
Income tax expense/(credit)	199	486	(59)
Financial income	0	0	(1,171)
Financial expense	21,388	9,565	11,053
Share-based payments (net of capitalized amounts)	324	1,316	2,069
Foreign exchange gains/(losses) on operating cash flows	(1,102)	1,010	238
Movement in inventory provision	629	2,113	2,291
Inventory write off	0	1,884	0
Impairment of property, plant and equipment	33	612	3,772
Impairment of intangible assets	2,144	1,596	5,833
Once off items	(186)	0	0
Liabilities related to financial assets (reversal)/written off	0	(800)	1,500
Gain on sale of business	0	0	(12,718)
Transformation provision	187	361	0
Other non-cash items	(908)	2,505	257
Operating cash flows before changes in working capital	(11,984)	(9,276)	(9,176)
Decrease/ (increase) in trade and other receivables	4,920	(2,368)	1,047
Decrease/ (increase) in inventories	90	(1,742)	(971)
Increase/ (decrease) in trade and other payables	1,391	8,185	(2,769)
Cash used in operations	(5,583)	(5,201)	(11,869)
Interest received	0	0	0
Income taxes received/(paid)	(346)	1,010	312
Net cash used in operating activities	(5,929)	(4,191)	(11,557)
Cash flows from investing activities
Payments to acquire intangible assets	(6,135)	(9,659)	(1,901)
Acquisition of property, plant and equipment	(88)	(405)	(803)
Payments to acquire financial asset	0	0	(700)
Proceeds from sale of business (net of transaction costs)	0	0	28,160
Payments to acquire trades or businesses	0	(12,904)	0
Net cash (used in)/generated by investing activities	(6,223)	(22,968)	24,756
Cash flows from financing activities
Issue of ordinary share capital including share premium (net of issuance costs)	547	7,391	0
Proceeds from shares to be issued	0	0	0
Net proceeds from senior secured term loan	15,000	30,176	5,000
Expenses paid in connection with debt financing	0	0	(147)
Repayment of senior secured term loan	0	0	(10,050)
Penalty for early settlement of term loan	0	0	(905)
Interest paid on senior secured term loan	0	(5,946)	(7,314)
Interest paid on convertible note	(300)	(300)	(300)
Interest paid on exchangeable notes	(8)	(8)	(8)
Payment of lease liabilities	(3,187)	(2,503)	(2,318)
Net cash generated by/(used in) financing activities	12,052	28,810	(16,042)
Decrease/(increase) in cash and cash equivalents and short-term investments	(100)	1,651	(2,843)
Effects of exchange rate movements on cash held	71	(175)	(44)
Cash and cash equivalents and short-term investments at beginning of year	5,167	3,691	6,578
Cash and cash equivalents and short-term investments at end of year	$ 5,138	$ 5,167	$ 3,691

CONSOLIDATED STATEMENT OF FINANCIAL POSITION - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Non-current assets
Property, plant and equipment	$ 5,302	$ 4,621
Goodwill and intangible assets	56,987	51,343
Financial assets	2,773	2,455
Deferred tax assets	3,924	3,553
Derivative financial instruments	249	166
Other assets	28	28
Total non-current assets	69,263	62,166
Current assets
Inventories	18,828	19,374
Trade and other receivables	11,480	16,065
Income tax receivable	456	518
Cash and cash equivalents	5,138	5,167
Total current assets	35,902	41,124
TOTAL ASSETS	105,165	103,290
Equity attributable to the equity holders of the parent
Share capital	40	4,190
Share premium	63,800	63,397
Treasury shares	(24,922)	(24,922)
Accumulated deficit	(116,169)	(79,117)
Translation reserve	(5,777)	(5,461)
Equity component of convertible note	6,709	6,709
Other reserves	4,337	23
Total deficit	(71,982)	(35,181)
Current liabilities
Senior secured term loan	108,015	0
Income tax payable	348	364
Trade and other payables	29,703	26,782
Provisions	345	2,454
Exchangeable notes and other borrowings	210	210
Lease liabilities	2,588	2,285
Total current liabilities	141,209	32,095
Non-current liabilities
Senior secured term loan	0	72,391
Derivative financial liability	3,320	1,658
Convertible note	16,330	15,401
Contingent consideration	0	1,813
Provisions	781	75
Lease liabilities	10,840	10,477
Deferred tax liabilities	4,667	4,561
Total non-current liabilities	35,938	106,376
TOTAL LIABILITIES	177,147	138,471
TOTAL EQUITY AND LIABILITIES	$ 105,165	$ 103,290